right-img

Home | Zacks: Analysts Expect Ascendis Pharma A/S (ASND) Will Announce Quarterly Sales of $160,000.00

Zacks: Analysts Expect Ascendis Pharma A/S (ASND) Will Announce Quarterly Sales of $160,000.00

June 30, 2018
Brokerages expect Ascendis Pharma A/S (NASDAQ:ASND) to report $160,000.00 in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Ascendis Pharma A/S’s earnings, with the lowest sales estimate coming in at $30,000.00 and the highest estimate coming in at $230,000.00. Ascendis Pharma A/S reported sales of $490,000.00 in […]
Read more at:https://www.americanbankingnews.com/2018/06/30/zacks-analysts-expect-ascendis-pharma-a-s-asnd-will-announce-quarterly-sales-of-160000-00.html

Site Created by finaceandbankingnewsnow.com